FDA Inspection 1181253 — Louisville Health, Louisville - Jewish Hospital
The FDA completed an inspection of Louisville Health, Louisville - Jewish Hospital on Oct 6, 2022 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 6, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Louisville, KY (United States)